·         WHO recommended Artemisinin Combination Therapy

·         Contains Artesunate and Amodiaquine

·         Available in 4 age ranges

·         Residual protection as a result of a half-life of over 30 days due to the Amodiaquine component

·         Vanilla flavoured children's formulation

·         Single unit granular doses for children

·         No need for reconstitution and refrigeration

·         No degradation due to hydrolysis

·         Convenient 3 days dosage regimen

·         Affordable and available in all healthcare outlets